ABS 2019: Three-fraction APBI proven feasible in clinical trial

Print Friendly, PDF & Email

Three-fraction APBI proven feasible in clinical trial

“Utilization of the shortest appropriate schedules could increase the proportion of women alive with a conserved breast by increasing the number of women with access to radiation therapy treatment that is realistic for them to do. We hope that ultrashort breast brachytherapy treatment, once further validated, will give breast cancer patients for whom breast-conservation surgery and radiation therapy may not seem otherwise possible, particularly in geographies with limited resources, this treatment option,”

Read Full Story
Next Previous Home